IFCC教育与管理部全球影响:中国多中心HbA1c质量评估研究
该研究通过教育研讨会和多中心研究评估中国30家中心HbA1c检测质量,所有中心室内和室间CV低于3%,均满足sigma≥2(TAE 5 mmol/mol)标准,展示了多利益相关方合作改善糖尿病检测的成功模式。
要点
- 30家中心HbA1c检测的室内和室间CV均低于3%(SI单位)。
- 所有实验室在TAE 5 mmol/mol(0.46% NGSP)下达到sigma≥2。
- 多利益相关方合作与教育研讨会促进了中国糖尿病检测的长期协作。
核心结论
- 多伙伴合作方法成功改善了中国的糖尿病检测,所有参与中心均达到IFCC公布的质量标准。
研究设计与样本
- 通过教育研讨会支持研究科学目标,中国30家中心接收相同的新鲜冷冻全血样本,采用IFCC二级参考方法赋值,并进行精密度(EP-5)和正确度研究。
主要发现
- 所有30家中心在低和高HbA1c水平下,室内和室间变异系数(CV)均低于3%(SI单位)。
- 所有个体实验室在总允许误差(TAE)5 mmol/mol(0.46% NGSP)下满足sigma≥2的标准。
关键数值与推荐
- 精密度和正确度研究采用EP-5方案,性能通过sigma度量评估。
- 质量达标标准为室内和室间CV低于3%(SI单位),且在TAE 5 mmol/mol(0.46% NGSP)下sigma≥2。
临床怎么用
- 该多利益相关方模式可推广至其他地区,以通过教育研讨和质量评估提升糖尿病检测质量。
- 达到IFCC质量标准为未来临床试验和扩大HbA1c检测应用奠定了基础。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background Diabetes mellitus is a major global issue and high quality testing is essential for the diagnosis and treatment of the disease. The IFCC Committee for the Education in the Utility of Biomarkers in Diabetes (C-EUBD) plays a global role in improving knowledge and understanding around diabetes testing. This paper describes a multi-stakeholder approach, to improving diagnostic and therapeutic testing for diabetes, using a multicentre study in China as an example of the global impact of the group. Methods Educational workshops were developed to support the scientific aims of the study in which 30 centres around China received identical, fresh frozen whole blood samples with values assigned using IFCC secondary reference methods and undertook precision (EP-5) and trueness studies. Performance was assessed using sigma metrics. Results A successful multi-stakeholder group was developed and sustained throughout the study through several educational workshops, which enabled the formation of a long-term collaboration with key opinion leaders and policy makers in China. All 30 centres showed good performance with within and between laboratory coefficient of variations (CVs) below 3% in SI units at both low and high haemoglobin A1c (HbA1c) levels. All individual laboratories met the criteria of a sigma of two or more at a total allowable error (TAE) of 5 mmol/mol (0.46% NGSP). Conclusions The study led to a successful multi-partner approach to improving diabetes testing in China. All centres involved in the study meeting the published IFCC quality criteria, paving the way for future clinical trials and an expanded role for HbA1c testing across the country.
引用
- English E, Weykamp C, Ji L, et al. The global impact of the International Federation of Clinical Chemistry and Laboratory Medicine, Education and Management Division: engaging stakeholders and assessing HbA1c quality in a multicentre study across China. Clin Chem Lab Med. 2018. PMID: 30044761. doi:10.1515/cclm-2018-0434
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。